Earnings Call · Q4 FY2022·2023-03-03

Q4 22EPS -100.00%*·Rev n/aQ3 22EPS -17.14%·Rev n/aQ2 22EPS -12.54%·Rev n/aQ1 22EPS +30.77%·Rev n/a⚠ consensus missing

DBV Technologies S.A. DBVT

Anne Pollak — Head of Investor Relations

Daniel Tassé — Chief Executive Officer (CEO)

Pharis Mohideen — Clinical Development or Medical Affairs Executive

Sébastien Robitaille — Chief Financial Officer (CFO)

+5.1%1d on move date+3.5% vs SPY3d+10.2%5d+23.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DBVT calls or request research access.

More DBVT calls Browse calls Request research access